Clinical Updates: Closing the Gap - Preventing Recurrent Fractures
This issue of "Osteoporosis: Clinical Updates" explores the problem of repeat fractures and what healthcare providers can do to prevent them. We take a look at an emerging model of care that has shown promise: the Fracture Liaison Service, or FLS, model. Principles of the FLS model can be incorporated into a wide variety of clinical settings, and is uniquely suited for primary care practice. Fee: Member- $0; Nonmember-$10
Initial Date: March 27, 2018
Expiration Date: April 30, 2020
Credits Available: 1 hour
Fee: Members-$0; Nonmembers- $10

Medical writer:                

Kelly A. Trippe, MA: No relationships to disclose

Guest reviewer:               

Avery Jackson, MD, FAANS FACS: No relationships to disclose

Lead Nurse Planner:       

Susan Randall, MSN, RN, FNP-BC: No relationships to disclose

Editors and content reviewers:

                Angelo Licata, MD, PhD:  No relationships to disclose

                Carolyn J. Bolognese, RN, CDE: No relationships to disclose

                Peggy Doheny, PhD, RN, CNS, ONC, FAAN: No relationships to disclose. 

Paul Miller, MD, FACP: Alexion: Research Support. Amgen: Consultant; Advisory Board; Research Support. Boehringer Ingelheim: Research Support. Diaachi: Research Support Immunodiagnostics: Research Support. Merck: Research Support. Merck Serono: Research Support. Novartis: Research Support. Radius: Consultant; Advisory Board; Research Support. Regeneron: Research Support. Roche Diagnostic: Research Support.

Jeri Nieves, PhD: No relationships to disclose

Mary Beth O’Connell, PharmD, BCPS: No relationships to disclose 

Rick Pope, MPAS, PA-C, DFAAPA: No relationships to disclose

Carol Sedlak, PhD, RN, CNS, ONC, CNE, FAAN: No relationships to disclose

Robert Westergan, MD: No relationships to disclose

NOF Clinical Director:

Andrea Singer, MD , FACP, CCD: Amgen: Consultant; Speakers Bureau / Teaching Engagements; Advisory Board. Eli Lilly : Consultant; Speakers Bureau / Teaching Engagements; Advisory Board. Hologic, Inc: Consultant. Medtronic: Consultant. Merck: Consultant. Radius: Consultant; Advisory Board. UCB: Consultant

For information about NOF’s Clinical Updates and its Editorial Board click here

Activity Description

The vast majority of hip fracture patients get no evaluation or treatment for the cause of their fracture: osteoporosis. Without treatment, bone quality continues to decline and additional fractures occur. Primary care providers can help close this gap in care. Focusing resources on highest risk patients and then following them to ensure receive optimal fracture prevention care.

This issue of "Osteoporosis: Clinical Updates" explores the problem of repeat fractures and what healthcare providers can do to prevent them. We take a look at an emerging model of care that has shown promise: the Fracture Liaison Service, or FLS, model. Principles of the FLS model can be incorporated into a wide variety of clinical settings, and is uniquely suited for primary care practice.  


Intended Audience

This continuing education activity is intended for use by health professionals who participate in the care of patients at risk for or suffering from osteoporosis, in the areas of primary care, endocrinology, geriatrics, gynecology, internal medicine, obstetrics, orthopedics, osteopathy, pediatrics, physiatry, radiology, rheumatology and physical therapy.

This includes physicians, nurse practitioners, registered nurses, pharmacists, physician assistants, technologists, researchers, public health professionals and health educators with an interest in osteoporosis and bone health.


Objectives
Upon completion of this activity the participant should be able to:

  • Identify factors that contribute to very low compliance with standards of care in patients who have experienced fragility fracture.

    Perform a clinical assessment to identify patients at risk of secondary fragility fracture.

    Contribute to postfracture patient care as part of a coordinated multidisciplinary team.

    Utilize technological and clinical tools to implement comprehensive fracture prevention in primary care practice.

    Explain the benefits of using a fracture liaison to organize and oversee the care of post-fracture patients.

CME Program Eligibility
Method of Participation in the Learning Process: Clinician learners will read and analyze the subject matter, conduct additional informal research through related internet searches on the subject matter, and complete a post-test assessment of knowledge and skills gained as a result of the activity.

After participating in this activity, the reader has the option of taking a post-test with a passing grade of 70% or better to qualify for continuing education credit for this activity. It is estimated it will take 1.0 hour(s) to complete the reading and take the post-test. Continuing education credit will be available for two years from the date of publication.


Accreditation


The National Osteoporosis Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The National Osteop
orosis Foundation designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The National Osteoporosis Foundation is accredited as a provider of continuing
nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. The National Osteoporosis Foundation designates this educational activity for a maximum of 1.0 continuing nursing education credit(s).

Other healthcare providers will also be able to receive a certificate of completion; nurse practitioners and physician assistants may request an AMA PRA Category 1 Credit(s)™ certificate of participation.

Disclosure of Commercial Support

It is the policy of the National Osteoporosis Foundation (NOF) to ensure balance, independence, objectivity, and scientific rigor in all its sponsored publications and programs. NOF requires the disclosure of the existence of any significant financial interest or any other relationship the sponsor, Editorial Board or Guest Contributors have with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. All authors and contributors to this continuing education activity have disclosed any real or apparent interest that may have direct bearing on the subject matter of this program.

Please be advised that NOF’s accreditation status with ACCME and ANCC does not imply endorsement by NOF, ACCME or ANCC of any commercial products displayed in conjunction with this activity or endorsement of any point of view.


Statement regarding OFF Label Use

Please be advised that any publication of the Osteoporosis Clinical Updates that discusses off-label use of any medications or devices will be disclosed to the participant.

Refund Policy
NOF offers no returns or refunds on online internet CME activities purchased through our store. All sales are final. Meeting and workshop registrations will be refunded in accordance with the cancellation policy of the meeting and/or workshop, as outlined at registration.


Type:     Internet Activity (Enduring Material)
42 Registered Users

National Osteoporosis Foundation

251 18th Street South, Suite 630, Arlington, VA 22202 I [p] 1 (800) 231-4222 • [f] 1 (703) 414-3742

The National Osteoporosis Foundation is a qualified 501(c)(3) tax-exempt organization and all donations to the organization are
tax deductible to the full extent allowable by law. NOF’s tax ID number is 36-3350532.